Pliant Therapeutics (PLRX) Change in Receivables (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly Change in Receivables of -$1.6 million for Q3 2023, up 54.95% year-over-year from -$1.0 million in Q3 2022, and up 7.98% quarter-over-quarter from -$1.7 million in Q2 2023.
Pliant Therapeutics (PLRX) Change in Receivables (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Change in Receivables for 4 consecutive years, with -$1.6 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Change in Receivables rose 54.95% year-over-year to -$1.6 million; the TTM figure through Jun 2024 stood at -$1.6 million (up 53.65% YoY), while the FY2023 annual figure was -$2.0 million, down 13120.0% from the prior year.
- Change in Receivables climbed to -$1.6 million in Q3 2023 per PLRX's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $24.7 million in Q1 2020 and bottomed at -$28.2 million in Q2 2020.
- Historically, Change in Receivables has averaged -$470133.3 across 4 years, with a median of -$220000.0 in 2021.
- On a YoY basis, Change in Receivables climbed as much as 1187.21% in 2022 and fell as far as 1494.09% in 2022.
- Pliant Therapeutics' Change in Receivables stood at $2.1 million in 2020, then tumbled by 81.94% to $388000.0 in 2021, then increased by 29.12% to $501000.0 in 2022, then tumbled by 415.37% to -$1.6 million in 2023.
- Business Quant data shows PLRX's Change in Receivables at -$1.6 million in Q3 2023, -$1.7 million in Q2 2023, and $1.3 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.58 Mn |
| Sep 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 501,000.00 |
| Dec 31, 2022 | 501,000.00 |
| Sep 30, 2022 | -3.51 Mn |
| Sep 30, 2022 | -3.51 Mn |
| Jun 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 3.74 Mn |
| Mar 31, 2022 | -749,000.00 |
| Mar 31, 2022 | -749,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Sep 30, 2021 | -220,000.00 |
| Sep 30, 2021 | -220,000.00 |
| Jun 30, 2021 | -344,000.00 |
| Jun 30, 2021 | -344,000.00 |